01—Abstract
Summary
Summary of the 10-Q filed November 9, 2011. Cited figures are marked; the original filing is the authoritative source.
Axon Enterprise, Inc. (AXON), formerly TASER International, Inc., reported a net income of $1.14 milliona for the third quarter of 2011, a significant turnaround from a net loss of $2.34 million in the same period of the previous year.
This improvement was driven by a 15.6% increase in net sales, reaching $24.4 millionb, primarily due to stronger domestic law enforcement sales and the introduction of the new TASER X2. Despite increased research and development expenses and a substantial litigation judgment expense, the company managed to improve its gross margin to 53.7% and reduce its SG&A expenses as a percentage of sales. For the first nine months of 2011, the company reported a net loss of $1.14 million, an improvement from a net loss of $4.19 million in the prior year period.
Net sales grew by 7.3% to $68.7 millionc. The company generated positive cash flow from operations of $14.6 million, a notable shift from a negative $2.4 million in the prior year, supported by operational improvements and effective working capital management. However, a significant litigation judgment expense of $3.3 million and an asset impairment charge of $1.4 million impacted the year-to-date results.
02—Key points
Key Highlights
- The company achieved profitability in the third quarter of 2011, reporting a net income of $1.14 million, a substantial improvement from a net loss of $2.34 million in Q3 2010.
- Net sales increased by 15.6% to $24.4 million in Q3 2011, driven by strong domestic law enforcement sales and the introduction of the new TASER X2.
- Gross margin improved significantly to 53.7% in Q3 2011, up from 49.4% in Q3 2010, indicating better cost management and product mix.
- For the nine months ended September 30, 2011, net cash provided by operating activities was $14.6 million, a marked improvement from a net cash used of $2.4 million in the same period of 2010.
- The company reported a substantial litigation judgment expense of $3.3 million in Q2 2011 related to the Turner case, impacting profitability for the nine-month period.
- An asset impairment charge of $1.4 million was recorded in Q2 2011 related to the abandonment of the Protector product line.
- TASER repurchased approximately $24.9 million of its common stock in the first nine months of 2011 under its authorized repurchase programs.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2011, Axon Enterprise, Inc. kept $0.05.
- Revenue$24.4M100.0%
- Cost of revenue−$11.3M46.3%
- Gross profit$13.1M53.7%
- Operating costs−$11.9M48.8%
- Operating income$1.2M5.0%
- Interest, other & tax−$75,8070.3%
- Net income$1.1M4.7%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2011filed November 9, 2011Financial Statements
Q3 FY2011 against Q3 FY2010
| Line item | Q3 FY2011Q3 FY2010 | Change |
|---|---|---|
| Revenue | $24.38M$21.08M | +15.6% |
| Cost of Revenue | $11.28M$10.67M | +5.7% |
| Gross Profit | $13.10M$10.42M | +25.8% |
| R&D Expenses | $2.36M$1.69M | +40.1% |
| SG&A Expenses | $9.48M$9.42M | +0.6% |
| Operating Income | $1.21M-$725K | +267.2% |
| Net Income | $1.14M-$2.34M | +148.7% |
| EPS (Basic) | $0.02$-0.04 | +150.0% |
| EPS (Diluted) | $0.02$-0.04 | +150.0% |
| Shares Outstanding (Basic) | 58.79M62.34M | −5.7% |
| Shares Outstanding (Diluted) | 60.04M62.34M | −3.7% |
05—Questions
Frequently Asked Questions
What was the company's profitability in the third quarter of 2011 compared to the prior year?
Axon Enterprise, Inc. (AXON) reported a net income of $1.14 million for the third quarter of 2011, a significant turnaround from a net loss of $2.34 million in the same period of the prior year. This indicates a strong operational improvement quarter-over-quarter.
What were the main drivers of the sales increase in the third quarter of 2011?
The company's net sales increased by 15.6% to $24.4 million in Q3 2011. This growth was primarily driven by stronger domestic law enforcement sales and the successful introduction and sales of the new TASER X2 product, alongside an increase in follow-on cartridge orders from international customers.
How did the company's cash flow from operations perform in the first nine months of 2011?
The company generated $14.6 million in net cash from operating activities for the first nine months of 2011. This is a substantial improvement compared to the $2.4 million used in operating activities during the same period in 2010, reflecting improved operational efficiency and working capital management.
Are there any significant expenses or charges impacting the company's financial results for the nine-month period?
Yes, the company incurred a litigation judgment expense of $3.3 million in the second quarter of 2011 related to the Turner case. Additionally, there was an asset impairment charge of $1.4 million in the second quarter of 2011 due to the decision to abandon the Protector product line. These significant charges impacted the overall net loss for the nine-month period.
06—Continue